These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 161840

  • 1. [Molybdocene dichloride as an antitumor agent (author's transl)].
    Köpf-Maier P, Leitner M, Voigtländer R, Köpf H.
    Z Naturforsch C Biosci; 1979 Dec; 34(12):1174-6. PubMed ID: 161840
    [Abstract] [Full Text] [Related]

  • 2. [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].
    Köpf-Maier P, Hesse B, Köpf H.
    J Cancer Res Clin Oncol; 1980 Jan; 96(1):43-51. PubMed ID: 7188941
    [Abstract] [Full Text] [Related]

  • 3. In vitro cell growth inhibition by metallocene dichlorides.
    Köpf-Maier P, Wagner W, Köpf H.
    Cancer Chemother Pharmacol; 1981 Jan; 5(4):237-41. PubMed ID: 7261252
    [Abstract] [Full Text] [Related]

  • 4. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
    Waern JB, Dillon CT, Harding MM.
    J Med Chem; 2005 Mar 24; 48(6):2093-9. PubMed ID: 15771451
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
    Köpf-Maier P, Hesse A.
    J Cancer Res Clin Oncol; 1984 Mar 24; 108(2):254-5. PubMed ID: 6540782
    [Abstract] [Full Text] [Related]

  • 7. Titanocene dichloride--the first metallocene with cancerostatic activity.
    Köpf H, Köpf-Maier P.
    Angew Chem Int Ed Engl; 1979 Jun 24; 18(6):477-8. PubMed ID: 111586
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
    Köpf-Maier P, Wagner W, Hesse B, Köpf H.
    Eur J Cancer (1965); 1981 Jun 24; 17(6):665-9. PubMed ID: 7308264
    [No Abstract] [Full Text] [Related]

  • 11. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
    Silvestru C, Socaciu C, Bara A, Haiduc I.
    Anticancer Res; 1990 Jun 24; 10(3):803-4. PubMed ID: 2369094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.
    Köpf-Maier P, Wagner W, Liss E.
    J Cancer Res Clin Oncol; 1983 Jun 24; 106(1):44-52. PubMed ID: 6684118
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Bara A, Socaciu C, Silvestru C, Haiduc I.
    Anticancer Res; 1991 Jun 24; 11(4):1651-5. PubMed ID: 1836124
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ionic rhenocene derivatives with antitumor activity.
    Köpf-Maier P, Klapötke T.
    Cancer Chemother Pharmacol; 1992 Jun 24; 29(5):361-6. PubMed ID: 1551174
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coordination chemistry of the antitumor metallocene molybdocene dichloride with biological ligands.
    Waern JB, Harding MM.
    Inorg Chem; 2004 Jan 12; 43(1):206-13. PubMed ID: 14704069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.